These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7049375

  • 1. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.
    Capizzi RL.
    Cancer Treat Rep; 1981; 65 Suppl 4():115-21. PubMed ID: 7049375
    [Abstract] [Full Text] [Related]

  • 2. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
    Schwartz SA, Morgenstern B, Capizzi RL.
    Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
    Jolivet J, Cole DE, Holcenberg JS, Poplack DG.
    Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
    [Abstract] [Full Text] [Related]

  • 5. Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer.
    Yap HY, Benjamin RS, Blumenschein GR, Hortobagyi GN, Tashima CK, Buzdar AU, Bodey GP.
    Cancer Treat Rep; 1979 Jan; 63(1):77-83. PubMed ID: 369695
    [Abstract] [Full Text] [Related]

  • 6. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults.
    Yap BS, McCredie KB, Keating MJ, Bodey GP, Freireich EJ.
    Cancer Treat Rep; 1981 Jan; 65 Suppl 1():83-7. PubMed ID: 6948610
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical use of methotrexate--with emphasis on use of high doses.
    Bertino JR.
    Cancer Treat Rep; 1981 Jan; 65 Suppl 1():131-5. PubMed ID: 6976829
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preliminary results of the combination methotrexate-asparaginase in patients with acute non lymphoid leukemia.
    Mandelli F, Amadori S, Pacilli L, Tribalto M.
    Biomedicine; 1978 Jun; 29(4):116-7. PubMed ID: 687752
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cells.
    De Soto JA, Bowen D, Davis JH, Southerland WM, Hawkins M.
    Anticancer Res; 2002 Jun; 22(2A):1007-9. PubMed ID: 12014617
    [Abstract] [Full Text] [Related]

  • 15. Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo.
    Bender RA, Nichols AP, Norton L, Simon RM.
    Cancer Treat Rep; 1978 Jul; 62(7):997-1003. PubMed ID: 688252
    [Abstract] [Full Text] [Related]

  • 16. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
    Shetty PA, Kurkure PA, Dasgupta A.
    Indian J Cancer; 1984 Jul; 21(1):45-9. PubMed ID: 6595214
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.